# Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation

> **NCT03073850** · PHASE4 · TERMINATED · sponsor: **Korea University Guro Hospital** · enrollment: 48 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Antiplatelet
- **DRUG:** Low dose oral anticoagulant
- **DRUG:** Standard dose oral anticoagulant

## Key facts

- **NCT ID:** NCT03073850
- **Lead sponsor:** Korea University Guro Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-23
- **Primary completion:** 2019-12-15
- **Final completion:** 2019-12-15
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** Majority of enrolled patients have withdrawn.
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073850, "Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03073850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*